2009
DOI: 10.1016/j.bmc.2009.09.023
|View full text |Cite
|
Sign up to set email alerts
|

Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(10 citation statements)
references
References 23 publications
0
9
0
Order By: Relevance
“…Likewise, other companies have also pursued dual SERT and NET inhibitors and 5-HT 1A receptor agonists (Hatzenbuhler et al, 2006(Hatzenbuhler et al, , 2008. Other multiple target strategies for development of monoamine transporters inhibitors with additional activity as antidepressants (Millan, 2006(Millan, , 2009 include combined NRI activity and 5-HT 2A receptor antagonism (Heffernan et al, 2008), SSRI activity and neurokinin 1 receptor antagonists (Ryckmans et al, 2002a,b) or histamine H 3 receptor antagonist (Barbier et al, 2007). However, so far no data from clinical trials have been reported for such compounds.…”
Section: B Novel Principles For Treatment Of Mood Disordersmentioning
confidence: 99%
“…Likewise, other companies have also pursued dual SERT and NET inhibitors and 5-HT 1A receptor agonists (Hatzenbuhler et al, 2006(Hatzenbuhler et al, , 2008. Other multiple target strategies for development of monoamine transporters inhibitors with additional activity as antidepressants (Millan, 2006(Millan, , 2009 include combined NRI activity and 5-HT 2A receptor antagonism (Heffernan et al, 2008), SSRI activity and neurokinin 1 receptor antagonists (Ryckmans et al, 2002a,b) or histamine H 3 receptor antagonist (Barbier et al, 2007). However, so far no data from clinical trials have been reported for such compounds.…”
Section: B Novel Principles For Treatment Of Mood Disordersmentioning
confidence: 99%
“…Indole is a ubiquitous structural motif which is present in a wide range of natural products and pharmaceutical molecules [1] . Among those structures, 3‐sulfonylindole derivatives are outstanding ones with special chemical and biological properties, such as used as 5‐HT 6 receptor ligands, [2] HIV‐1 non‐nucleoside reverse‐transcriptase inhibitors, [3] 5‐HT 2A receptor antagonists and norepinephrine reuptake inhibitors, [4] and orexin receptor antagonists [5] (Figure 1). As a result, the construction of 3‐sulfonylindoles has drawn great attention from many areas.…”
Section: Figurementioning
confidence: 99%
“…General Procedure for Synthesis of 3-(Phenylthio)-1H-indole Derivatives. Thioether derivatives were prepared following a modified procedure: 19 To a solution of 1H-indole (1 equiv) and thiophenol derivatives (1.1 equiv) in ethanol (20 mL) was added a solution of potassium iodide (1.1 equiv) and iodine (1.1 equiv) in 3:1 (v/v) water/ethanol (20 mL) at room temperature under open air. The resulting blackish red reaction mixture was attached with reflux condenser and stirred at 60 °C for 3 days.…”
Section: ■ Experimental Sectionmentioning
confidence: 99%